Pricing Log in Create free account

BioNexus Gene Lab Corp. (BGLC) vs Bon Natural Life Limited (BON)

BioNexus Gene Lab Corp. and Bon Natural Life Limited are both Specialty Chemicals companies. Bon Natural Life Limited is the larger, with a market value of $9.1M against $2.4M — 3.7× the size. BioNexus Gene Lab Corp. has negative trailing earnings, so its P/E is not meaningful; Bon Natural Life Limited trades at 0.9×. Bon Natural Life Limited grew revenue faster over the last twelve months: 53.3% against −67.3%. Bon Natural Life Limited has the higher net margin (18.4% vs −82.4%) and the higher return on invested capital (0.00% vs −37.2%). Across the 16 metrics below, Bon Natural Life Limited leads on 11 and BioNexus Gene Lab Corp. on 5.

Valuation

Metric BGLC BON Specialty Chemicals median
P/E n/m 0.88 26.45
P/S 0.64 n/m 1.64
P/B 0.26 n/m 1.84
Price to free cash flow n/m n/m 21.25
EV/EBITDA 0.63 n/m 12.93
EV/Sales (0.47) (0.12) 1.90
Earnings yield (151.81%) 113.51% 2.47%
Free cash flow yield (42.55%) 0.00% 2.20%

Profitability

Metric BGLC BON Specialty Chemicals median
Gross margin 12.34% 30.90% 27.84%
Operating margin (79.62%) 0.00% 5.64%
Net margin (82.36%) 18.39% 4.26%
Free cash flow margin (27.30%) 0.00% 4.75%
Return on equity (33.66%) 0.00% 3.73%
Return on assets (28.38%) 0.00% 1.16%
Return on invested capital (37.16%) 0.00% 3.21%

Growth

Metric BGLC BON Specialty Chemicals median
Revenue growth (TTM) (67.27%) 53.31% 7.03%
EPS growth (last fiscal year) (79.49%) (116.94%) (8.48%)
Revenue growth, 5-year CAGR (8.20%) 0.49% 6.27%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGLC BON Specialty Chemicals median
Debt to equity 0.01 0.04 0.59
Current ratio 6.08 1.83 2.16
Net debt to EBITDA 1.49 12.88 2.03

Dividend

Metric BGLC BON Specialty Chemicals median
Dividend yield — — 1.84%
Payout ratio — — 0.40

Size

Metric BGLC BON Specialty Chemicals median
Market cap 2.43m 9.07m 1.95b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack